Skip to Content

EADV 2026: Placebo Response in Hidradenitis Suppurativa Trials

Placebo responses can complicate the interpretation of clinical trials investigating immunomodulatory treatments for hidradenitis suppurativa (HS). In this MEDtalk, Nina Qiu, Medical Student, Bispebjerg Hospital, Copenhagen, Denmark, presents a systematic review and meta-analysis of 39 randomized controlled trials, exploring the magnitude of placebo responses, factors associated with them, and their implications for future trial design.

Nina Qiu

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top